GERN
Price
$1.27
Change
+$0.02 (+1.60%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
810.28M
50 days until earnings call
IRON
Price
$62.11
Change
+$1.77 (+2.93%)
Updated
Sep 17, 12:27 PM (EDT)
Capitalization
2.08B
50 days until earnings call
Interact to see
Advertisement

GERN vs IRON

Header iconGERN vs IRON Comparison
Open Charts GERN vs IRONBanner chart's image
Geron
Price$1.27
Change+$0.02 (+1.60%)
Volume$121.15K
Capitalization810.28M
Disc Medicine
Price$62.11
Change+$1.77 (+2.93%)
Volume$300
Capitalization2.08B
GERN vs IRON Comparison Chart in %
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. IRON commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a Hold and IRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (GERN: $1.25 vs. IRON: $60.34)
Brand notoriety: GERN and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 119% vs. IRON: 88%
Market capitalization -- GERN: $810.28M vs. IRON: $2.08B
GERN [@Biotechnology] is valued at $810.28M. IRON’s [@Biotechnology] market capitalization is $2.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 4 TA indicator(s) are bullish while IRON’s TA Score has 3 bullish TA indicator(s).

  • GERN’s TA Score: 4 bullish, 5 bearish.
  • IRON’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, IRON is a better buy in the short-term than GERN.

Price Growth

GERN (@Biotechnology) experienced а -8.09% price change this week, while IRON (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was +5.87%, and the average quarterly price growth was +34.62%.

Reported Earning Dates

GERN is expected to report earnings on Nov 06, 2025.

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.08B) has a higher market cap than GERN($810M). IRON YTD gains are higher at: -4.827 vs. GERN (-64.689). GERN has higher annual earnings (EBITDA): -58.41M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. GERN (388M). IRON has less debt than GERN: IRON (30.9M) vs GERN (122M). GERN has higher revenues than IRON: GERN (164M) vs IRON (0).
GERNIRONGERN / IRON
Capitalization810M2.08B39%
EBITDA-58.41M-142.42M41%
Gain YTD-64.689-4.8271,340%
P/E RatioN/AN/A-
Revenue164M0-
Total Cash388M650M60%
Total Debt122M30.9M395%
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GERNIRON
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 27 days ago
73%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
76%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGLYX18.700.08
+0.43%
JPMorgan Small Cap Growth R4
POAGX51.09N/A
N/A
PRIMECAP Odyssey Aggressive Growth
LIDOX9.97N/A
N/A
Lord Abbett International Value F3
SXPRX54.12-0.07
-0.13%
DWS S&P 500 Index R6
BTEEX15.68-0.05
-0.33%
Baron Technology Retail

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with KMSTF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.73%
KMSTF - IRON
54%
Loosely correlated
N/A
SYRE - IRON
52%
Loosely correlated
-0.13%
CGON - IRON
51%
Loosely correlated
+3.35%
CRNX - IRON
50%
Loosely correlated
+0.98%
ETNB - IRON
50%
Loosely correlated
-0.62%
More